Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› α6β4 nAChR
α6β4 nAChR
(1 companies · 2 programs)
Companies with an active program directed at α6β4 nAChR.
Rapport Therapeutics, Inc.
RAPP
RAP-641
— Chronic Pain
Phase 1
RAP-641
— Migraine
Phase 1